Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;157(3):604-612.
doi: 10.1002/ijgo.13860. Epub 2021 Aug 25.

Association of mid-trimester maternal angiogenic biomarkers with small-for-gestational-age infants in an urban Zambian cohort: a nested case-control study

Affiliations

Association of mid-trimester maternal angiogenic biomarkers with small-for-gestational-age infants in an urban Zambian cohort: a nested case-control study

Chileshe M Mabula-Bwalya et al. Int J Gynaecol Obstet. 2022 Jun.

Abstract

Objective: To investigate whether angiogenic biomarker concentrations differ between women who deliver small-for-gestational-age (SGA) infants (<10th centile birth weight for gestational age) compared with controls, because identifying SGA risk early could improve outcomes.

Methods: This case-control study compared serum concentrations of angiogenic biomarkers before 24 weeks of pregnancy from 62 women who delivered SGA infants (cases) and 62 control women from an urban Zambian cohort. Odds of delivering an SGA infant were calculated using conditional logistic regression.

Results: Placental growth factor (PlGF), soluble fms-like tyrosine kinase (sFLT-1) and soluble endoglin (sEng) in controls were 37.74 pg/mL (interquartile range [IQR] 23.12-63.15), 2525.18 pg/mL (IQR 1502.21-4265.54) and 2408.18 pg/mL (IQR 1854.87-3017.94), respectively. SGA cases had higher PlGF (40.50 pg/mL, IQR 22.81-67.94) and sFLT-1 (2613.06 pg/mL, IQR 1720.58-3722.50), and lower sEng (2038.06 pg/mL, IQR 1445.25-3372.26). Participants with sEng concentration below and concomitant sFLT-1 concentration above their respective thresholds (n = 40) had five-fold higher odds of SGA (adjusted odds ratio 4.77, 95% confidence interval 1.61-14.1; P = 0.005).

Conclusion: Biomarker concentrations were similar between cases and controls. Participants with concomitant low sEng and high sFLT-1 had the highest odds of SGA, suggesting that a combination of biomarkers may better for predicting SGA than single biomarkers.

Keywords: Zambia; birth weight; fetal growth; placental angiogenesis; small for gestational age.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Study sample selection flow diagram
FIGURE 2
FIGURE 2
Concentrations of maternal serum angiogenic biomarkers (pg/mL) between infants born small for gestational age (SGA) and controls, N = 124 [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3
FIGURE 3
Restricted cubic spline of soluble endoglin (sEng) concentration (pg/mL) by probability of small for gestational age <10th centile (SGA), N = 124 [Colour figure can be viewed at wileyonlinelibrary.com]

References

    1. Marchant T, Willey B, Katz J, et al. Neonatal mortality risk associated with preterm birth in East Africa, adjusted by weight for gestational age: individual participant level meta‐analysis. PLoS Med. 2012;9(8):e1001292. - PMC - PubMed
    1. Lavin T, Preen DB, Pattinson R. Timing and cause of perinatal mortality for small‐for‐gestational‐age babies in South Africa: critical periods and challenges with detection. Matern Health Neonatol Perinatol. 2016;2:11. - PMC - PubMed
    1. Vollmer B, Edmonds CJ. School age neurological and cognitive outcomes of fetal growth retardation or small for gestational age birth weight. Front Endocrinol. 2019;10:186. - PMC - PubMed
    1. Strauss RS. Adult functional outcome of those born small for gestational age: twenty‐six‐year follow‐up of the 1970 British Birth Cohort. JAMA. 2000;283(5):625‐632. - PubMed
    1. Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011;41(6):158‐176. - PMC - PubMed